Onalan Tugba, Colkesen Fatih, Akcal Tacettin, Gerek Mehmet Emin, Akkus Fatma Arzu, Evcen Recep, Kilinc Mehmet, Aykan Filiz Sadi, Arslan Sevket
Division of Allergy and Clinical Immunology, Department of Internal Medicine, Faculty of Medicine, Necmettin Erbakan University, Konya, Turkey.
Gastroenterology Clinic, Sanliurfa Training and Research Hospital, Şanlıurfa, Turkey.
Int Arch Allergy Immunol. 2025;186(3):212-220. doi: 10.1159/000541206. Epub 2024 Oct 3.
Although separate immunogenic mechanisms are involved, IgE-type sensitization to wheat and celiac disease (CD) may coexist. We observationally assessed the importance of this relationship in daily practice using CD and wheat sensitization screenings.
Celiac antibody (CA) screening and food prick tests (FPTs) were requested simultaneously from patients who presented to the Allergy Clinic between January 2022 and December 2023 and had any complaint accompanied by CD symptoms/findings (non-celiac group). Patients with positive CA (CA+) underwent endoscopy. As another group, FPT results were recorded for patients previously diagnosed with CD following a gluten-free diet (celiac group).
In total, 169 patients (124 non-celiac and 45 celiac) were included in the study. Wheat prick positivity (WP+) was observed in 1 patient with CD. Among 65 WP+ patients without a CD diagnosis, 14 (20.3%) tested positive for CA+, and histopathology detected CD in 4 of these cases. Among the 59 WP- patients, 4 (8.8%) had CA+. The CA+ status of those with WP+ was significantly higher than those with WP- (p = 0.023).
The 4 patients unaware of their CD exhibited WP+, with a higher rate of CA+ observed in the WP+ group. The association between WP+ and CA+ suggests that an impaired intestinal barrier may lead to simultaneous T helper 1 and 2 type inflammatory responses. Although different types of sensitization to the same food would not typically be expected, growing evidence indicates that this phenomenon does occur. Further studies are necessary to confirm these findings and to explore the underlying causes.
尽管涉及不同的免疫原机制,但对小麦的IgE型致敏与乳糜泻(CD)可能共存。我们通过CD和小麦致敏筛查,观察性评估了这种关系在日常实践中的重要性。
2022年1月至2023年12月期间到过敏诊所就诊且有任何伴有CD症状/体征的患者(非乳糜泻组),同时进行了乳糜泻抗体(CA)筛查和食物点刺试验(FPT)。CA阳性(CA+)的患者接受了内镜检查。作为另一组,记录了先前诊断为CD并遵循无麸质饮食的患者的FPT结果(乳糜泻组)。
该研究共纳入169例患者(124例非乳糜泻患者和45例乳糜泻患者)。1例CD患者出现小麦点刺阳性(WP+)。在65例未诊断为CD的WP+患者中,14例(20.3%)CA+检测呈阳性,其中4例经组织病理学检测确诊为CD。在59例WP-患者中,4例(8.8%)CA+呈阳性。WP+患者的CA+状态显著高于WP-患者(p = 0.023)。
4例未意识到自己患有CD的患者表现为WP+,WP+组中CA+的发生率更高。WP+与CA+之间的关联表明,肠道屏障受损可能导致同时出现辅助性T细胞1型和2型炎症反应。虽然通常不会预期对同一种食物有不同类型的致敏,但越来越多的证据表明这种现象确实存在。需要进一步研究来证实这些发现并探索其潜在原因。